GlassScriptPhysician profile
Ali R Khan
NPI 1215052121
$5,301.73
in general payments reported to CMS, 2019-2025
15 companies · $16.32 in 2025
The $16.32 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.72 · 2021: $547 · 2022: $3,395 · 2023: $1,271 · 2024: $33.17 · 2025: $16.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $860 · Food and Beverage: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $859.85 |
| Food and Beverage | $460.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,558.81 | 2021-2023 | Ellipsys Vascular Access System |
| Bard Peripheral Vascular, INC. | $1,014.68 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $159.37 | 2021-2022 | |
| Glaxosmithkline, LLC. | $133.91 | 2022-2025 | Benlysta |
| Astrazeneca Pharmaceuticals LP | $97.13 | 2021-2023 | Farxiga |
| Conmed Corporation | $83.33 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.44 | 2022 | |
| Mallinckrodt Enterprises LLC | $39.72 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $34.73 | 2022 | |
| Travere Therapeutics, INC. | $34.33 | 2023 | |
| Amgen INC. | $33.16 | 2023-2024 | Aranesp, Tavneos |
| Abbott Laboratories | $25.85 | 2023 | Proclaim |
| Akebia Therapeutics INC | $19.17 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.65 | 2024 | Jardiance |
| Itamar Medical INC | $10.45 | 2023 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.